| Application no. and date | 13737808.9 (espacenet) (Federated) (European Patent Register), 20130621 | | Patent/reg. no. and date | DK/EP 2866825, 20200408 | | Publication date | 20150506 | | Priority no. and date | EP 12174535, 20120701, US 201261694837 P, 20120830, EP 12186781, 20121001, US 201261708162 P, 20121001 | | EP pub. no. and date |
EP 2866825 20150506 | | Effective date | | | Applicant/owner | Novo Nordisk A/S, Novo Allé 1, 2880 Bagsværd, DK | | Applicant ref. no. | P73233DK01 | | Inventor | JENSEN, Christine Bjørn, Novo Allé, 2880 Bagsværd, DK,
RASMUSSEN, Mads Frederik, Novo Allé, 2880 Bagsværd, DK,
ZDRAVKOVIC, Milan, Novo Allé, 2880 Bagsværd, DK,
KRISTENSEN, Peter, Novo Allé, 2880 Bagsværd, DK | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 38/26 (2006.01) , A61P 3/04 (2006.01) | | Title | ANVENDELSE AF LANGSTIDSVIRKENDE GLP-1-PEPTIDER | | Int. application no. | EP2013063004 | | Int. publication no. | WO2014005858 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
